Optimal designs for random effect models with correlated errors with
  applications in population pharmacokinetics by Dette, Holger et al.
ar
X
iv
:1
01
1.
33
33
v1
  [
sta
t.A
P]
  1
5 N
ov
 20
10
The Annals of Applied Statistics
2010, Vol. 4, No. 3, 1430–1450
DOI: 10.1214/09-AOAS324
c© Institute of Mathematical Statistics, 2010
OPTIMAL DESIGNS FOR RANDOM EFFECT MODELS WITH
CORRELATED ERRORS WITH APPLICATIONS
IN POPULATION PHARMACOKINETICS1
By Holger Dette2, Andrey Pepelyshev and Tim Holland-Letz
Ruhr University at Bochum, St. Petersburg State University and
Ruhr University at Bochum
We consider the problem of constructing optimal designs for pop-
ulation pharmacokinetics which use random effect models. It is com-
mon practice in the design of experiments in such studies to as-
sume uncorrelated errors for each subject. In the present paper a
new approach is introduced to determine efficient designs for nonlin-
ear least squares estimation which addresses the problem of corre-
lation between observations corresponding to the same subject. We
use asymptotic arguments to derive optimal design densities, and the
designs for finite sample sizes are constructed from the quantiles of
the corresponding optimal distribution function. It is demonstrated
that compared to the optimal exact designs, whose determination is
a hard numerical problem, these designs are very efficient. Alterna-
tively, the designs derived from asymptotic theory could be used as
starting designs for the numerical computation of exact optimal de-
signs. Several examples of linear and nonlinear models are presented
in order to illustrate the methodology. In particular, it is demon-
strated that naively chosen equally spaced designs may lead to less
accurate estimation.
1. Introduction. The work presented in this paper is motivated by some
problems encountered in the design of experiments in a clinical trial to es-
tablish the pharmacokinetics of UzaraR©, a digitoxin related herbal diarrhea
medication [based on Thu¨rmann, Neff and Fleisch (2004)]. These kinds of
trials pose methodological design challenges because they require the esti-
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mation of global population parameters in the presence of correlated mea-
surement errors. The trial in question included a number of patients each
given an oral application of UzaraR© as well as, after a washout period, an
intravenous application of digoxin (Lanicor R©), where in both cases the re-
sulting serum concentration of digitoxin was measured repeatedly during
the next 36 hours.
The relation between the time and the concentration in the analysis of the
UzaraR© trial can be described using the theory of one-compartment models
with oral and, respectively, intravenous applications [Atkinson et al. (1993),
Shargel (1993)]. In the intravenous case, the medication reaches the maxi-
mum concentration in the blood almost immediately, and, after that, it is
gradually eliminated from the body over time. Thus, the digitoxin concen-
tration is modeled using the exponential elimination model
η(t, b) = b1e
−b2t.(1.1)
In the case of the oral application, there is a gradual build up of the con-
centration in the blood as the medication is absorbed through the digestive
tract, while there is a simultaneous elimination process of the medication
in the blood. Therefore, the concentration function is the solution of the
differential equation of these two parallel processes. The resulting function
η(t, b) = b3(e
−b1t − e−b2t)(1.2)
is known as the (3 parameter) Bateman function [Garrett (1994)]. In both
models, the function η(t, b) denotes the concentration function, t is the time
(in hours), b = (b1, b2) and, respectively, b = (b1, b2, b3) are the vectors of
parameters. The parameters are assumed to vary between patients and the
aim of the experiment is to estimate their global means (and sometimes
variances) over all patients.
Measurements within the same patient are usually correlated, and we
assume this correlation to be proportional to the time lag between measure-
ments, which is plausible as the random errors are usually caused by tempo-
rary changes in the patients physical condition. Measurements for different
patients are assumed to be independent. In the trial at question Thuermann
considered n = 15 (oral), respectively, n = 14 (intravenous) measurements
each on K = 18 patients. After a preliminary discussion with experts the
measurements were taken at nonoptimized time points. An approximation
of the covariance of a single patient can then be expressed as
Σpop =
∂η(t, b)
∂b
T
Vp
∂η(t, b)
∂b
+ Vε,(1.3)
where η(t, b) = (η(t1, b), . . . , η(tn, b))
T denotes the vector of expected re-
sponses at t1, . . . , tn and Vε is the covariance matrix corresponding to this
OPTIMAL DESIGNS FOR RANDOM EFFECT MODELS 3
data. This expression includes two sources of variation, the usual variation
Vε caused by random errors as well as the additional variation Vp due to the
random effect.
Situations of this kind are rather common in the evaluation of the phar-
macokinetics and the pharmacodynamics of drugs [see Buelga et al. (2005),
Colombo et al. (2006), among others]. The corresponding processes are usu-
ally modeled by linear or nonlinear random effects models, which try to esti-
mate the population parameters, that is, the mean and the inter-individual
variability of the parameters. Under the additional assumption of a normal
distribution, the population characteristics are usually estimated by maxi-
mum likelihood methods. In many cases, the likelihood cannot be evaluated
explicitly and approximations are used to calculate the estimate. Efficient
algorithms for estimation are available for this purpose [see Aarons (1999)].
Loosely speaking, under a Gaussian assumption this approach corresponds
to weighted nonlinear least squares estimation. It was pointed out by sev-
eral authors that the application of an appropriate design in these studies
can substantially increase the accuracy of estimation of the population pa-
rameters. Usually, the construction of a good design is based on the Fisher
information matrix which cannot be derived explicitly in pharmacokinetic
models with random effects. For this reason, many authors propose an ap-
proximation of the likelihood [see, e.g., Mentre´, Mallet and Baccar (1997),
Retout, Mentre´ and Bruno (2002), Retout and Mentre´ (2003), Schmelter
(2007a, 2007b), among others], which is used to derive an approximation
for the Fisher information matrix. This matrix is considered in various op-
timality criteria, which have been proposed for the construction of optimal
designs for random effect regression models.
In the present paper the investigation is motivated by the following is-
sues. First, the estimation of the population mean and the construction
of corresponding optimal designs for population pharmacokinetics strongly
depends on the Gaussian assumption, which is usually made for compu-
tational convenience. Moreover, the maximum likelihood estimates may be
inconsistent if the basic distributional assumption is violated. As a con-
sequence, the derived optimal designs might be inefficient. Second, most
authors derive the approximation for the Fisher information matrix under
the additional assumption that the random errors corresponding to the mea-
surements of each individual are uncorrelated [see, e.g., Retout, Duffull and
Mentre (2001), Retout, Mentre´ and Bruno (2002) and Retout and Mentre´
(2003), among many others]. However, this assumption is not realistic in
many applications of population pharmacokinetics. Thus, a general concept
for constructing optimal designs in the presence of correlated observations
is still missing. Third, even if the Gaussian assumption and the assumption
of uncorrelated errors for each subject can be justified, the numerical con-
struction of the estimate and the corresponding optimal design is extremely
hard.
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In the present paper we address these issues. To derive a good design,
we consider nonlinear least squares estimation in random effect regression
models. Note that this estimation does not require a specification of the
underlying distributions. For this estimation, we introduce a methodology
which can be used to derive efficient or optimal designs in very general
situations. More precisely, we embed the discrete optimal design problem in
a continuous optimal design problem, where a nonlinear functional of the
design density has to be minimized or maximized. This approach takes into
account the correlation dependence and yields an asymptotic optimal design
density, which has to be determined numerically in all cases of practical
interest. For finding the optimal density, we propose an algorithm based on
polynomial approximation. For a fixed sample size and for each individual,
an exact design can be obtained from the quantiles of the corresponding
optimal distribution function. It is demonstrated by examples that these
designs are very efficient. Moreover, the designs, derived from the asymptotic
optimal design density, are very good starting designs for any procedure of
local optimization for finding the exact optimal designs. To our knowledge,
the proposed method is the first systematic approach to determine optimal
designs for linear and nonlinear mixed effect models with correlated errors.
The remaining part of this paper is organized as follows. In Section 2 we
consider the case of a linear random effect model and explain the basic design
concepts. In Section 3 we introduce the approach for deriving the asymptotic
optimal designs for linear regression models with correlated observations by
employing results of Bickel and Herzberg (1979). In Section 4 we present
results for nonlinear regression models with correlated random errors and
derive D-optimal designs and optimal designs for estimating the area under
the curve in the compartmental model. Finally, the UzaraR© and Lanicor R©
trials are re-analyzed and optimal designs for the model (1.2) are determined.
In particular, we show that the design proposed by the experts is rather
efficient, while a naively chosen equidistant design can yield substantially
less accurate estimates.
2. Statement of the problem. Consider the common random effect linear
regression model
Yij = b
T
i g(tij) + εij , i= 1, . . . ,K; j = 1, . . . , ni,(2.1)
where Yij denotes the jth observation of the ith subject at the experimen-
tal condition tij , ε11, . . . , εK,nK are centered random variables with vari-
ances depending on t, Var(εij) = σ
2h2(tij) for some positive function h(t),
g(t) = (g1(t), . . . , gp(t))
T is a given vector of linearly independent regression
functions, and bi is a p-dimensional random vector representing the individ-
ual parameters of the ith subject, i= 1, . . . ,K. The explanatory variables tij
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can be chosen by the experimenter from a compact interval T . We assume
that errors εi = (εi1, . . . , εini) for different subjects are independent, but the
errors for the same subject are correlated, that is,
Cov(εij , εis) = σ
2h(tij)h(tis)(γr(tij − tis) + (1− γ)δj,s),(2.2)
where γ ∈ [0,1] is a constant, r(t) is a given correlation function such that
r(0) = 1, and δj,s denotes Kronecker’s symbol. Let Vε be the corresponding
covariance matrix. Assume that the individual parameters bi are drawn from
a population distribution with mean β and covariance matrix Vp, and they
are independent of the random variables εi. This means that the covariance
between two observations at the time tij and the time tis (j 6= s) is
Cov(Yij, Yis) = g
T (tij)Vpg(tis) + σ
2h(tij)h(tis)γr(tij − tis),
while the variance of Yij is given by g
T (tij)Vpg(tij)+σ
2h2(tij). It was shown
by Schmelter (2007b) that an optimal design necessarily advises the exper-
imenter to perform observations of all subjects at the same experimental
settings, that is, tij = tj (i= 1, . . . ,K, j = 1, . . . , n). Consequently, we define
an exact design ξ = {t1, . . . , tn} as an n-dimensional vector which describes
the experimental conditions for each subject. Without loss of generality, we
assume that the design points are ordered, t1 < · · ·< tn.
Suppose that n observations are taken according to the design ξ. Then
the model (2.1) for the ith subject can be written as
Yi =Xgbi + εi; i= 1, . . . ,K,(2.3)
where Yi = (Yi1, . . . , Yin)
T , the matrixXg is given byXg = (g(t1), . . . , g(tn))
T ,
and εi is now a centered random variable with variance σ
2h2(ti). This model
is a special case of the random-effect models discussed in Harville (1976),
which are called generalized MANOVA. According to Fedorov and Hackl
(1997), the (ordinary) least square estimate of β minimizes
K∑
i=1
n∑
j=1
h−2(tj)(Yij − f(tj)β)
2.
Define f(t) = g(t)/h(t) and X = (f(t1), . . . , f(tn))
T . Then the covariance
matrix of the ordinary least squares estimate βˆOLS is given by
D(βˆOLS) =
1
K
(XTX)−1XT (Vε +XVpX
T )X(XTX)−1
(2.4)
=
1
K
((XTX)−1XTVεX(X
TX)−1 + Vp).
Alternatively, if the covariance matrix Vε of the errors and the covariance
matrix of the random effects Vp were known (or can be well estimated), the
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(weighted) least squares statistic
βˆWLS =
1
K
K∑
i=1
(XT (Vε +XVpX
T )−1X)−1XT (Vε +XVpX
T )−1Yi,(2.5)
can be used to estimate the parameter β. The covariance matrix of the
estimate βˆWLS is given by
D(βˆWLS) =
1
K
(XT (Vε +XVpX
T )−1X)−1.(2.6)
Since the expression (2.4) is simpler than (2.6) (which requires two dif-
ferent inversions), the design methodology developed in this paper is based
on the covariance matrix of the ordinary least squares estimate. Addition-
ally, we will demonstrate that the optimal designs obtained by minimizing
functionals of the covariance matrix of the ordinary least squares estimate
are also very efficient for weighted least squares estimation.
We call a design optimal design if it minimizes an appropriate functional
of the covariance matrix of the least squares estimate. Since we consider
optimality criteria that are linear with respect to scalar multiplication of
the covariance matrix, we put K = 1 without loss of generality.
3. Asymptotic optimal designs. Although the theory of optimal design
has been discussed intensively for uncorrelated observations [see, e.g., Fe-
dorov (1972), Pa´zman (1986) and Atkinson and Donev (1992)], less results
can be found for dependent observations. For linear and nonlinear random
effect models, optimal designs under the assumption of uncorrelated errors
have been investigated in Schmelter (2007a, 2007b), Mentre´, Mallet and
Baccar (1997) and Retout and Mentre´ (2003), among others. For fixed effect
regression models with the presence of correlated errors, it was suggested to
derive optimal designs by asymptotic considerations. Sacks and Ylvisaker
(1966, 1968) have considered a fixed design space, where the number of
design points in this set tends to infinity. As a result, the asymptotic op-
timal designs depend only on the behavior of the correlation function in a
neighborhood of the point 0. In the present paper we use the approach of
Bickel and Herzberg (1979) and Bickel, Herzberg and Schilling (1981), who
have considered a design interval expanding proportionally to the number
of observation points. This case is equivalent to the consideration of a fixed
interval with the correlation function depending on the sample size. To be
precise, we assume that the design space is given by an interval T and the
design points of a sequence of designs ξn = {t1n, . . . , tnn} are generated by a
function a(·) in the form
tjn = a((j − 1)/(n− 1)), j = 1, . . . , n;(3.1)
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and a : [0,1]→ T denotes the inverse of a distribution function. Note that the
function a(·) is obtained from the density of the weak limit of the sequence
ξn as n→∞. For example, if T = [−1,1], the function a(u) = (2u− 1) cor-
responds to the equally-spaced designs with distribution function a−1(x) =
x+1
2 and density (a
−1)′(x) = 12I[−1,1](x). Furthermore, we assume that the
correlation function r(t) of the errors εi in (2.2) depends on n in the form
rn(t) = ρ(nt),(3.2)
such that ρ(t) = o(t) as t→∞. For the numerical construction of asymptotic
optimal designs, we derive an asymptotic representation for the covariance
matrix of the least squares estimate in the following lemma. For this purpose,
we impose the following regularity assumptions:
(C1) The functions f1(t), . . . , fp(t) are linearly independent, bounded on the
interval T and satisfy the first order Lipschitz condition:
|fi(t)− fi(s)| ≤M |t− s| and
|fi(t)| ≤M for all t, s ∈ T, i= 1, . . . , p.
(C2) The function a(·) is twice differentiable and there exists a positive
constant M <∞ such that for all u ∈ (0,1),
1
M
≤ a′(u)≤M, |a′′(u)| ≤M.(3.3)
(C3) The correlation function ρ is differentiable with bounded derivative
and satisfies ρ′(t)≤ 0 for sufficiently large t.
Assumption (C1) refers to the continuity of the response as a function of t
and it is satisfied for most of the commonly used regression models. More-
over, most of the commonly used correlation structures satisfy assumption
(C3) on a compact interval. Finally, assumption (C2) refers to the charac-
teristics of a design, requiring, loosely speaking, that observations should
not be clustered. This is quite reasonable due to ethical aspects. The follow-
ing result is obtained by similar arguments as given in Bickel and Herzberg
(1979) and, hence, its proof is omitted.
Lemma. Assuming that conditions (C1), (C2) and (C3) are satisfied,
then the covariance matrix of the least squares estimate have the form
D(βˆOLS) =
σ2
n
(W−1(a) + 2γW−1(a)R(a)W−1(a)) + Vp + o
(
1
n
)
,(3.4)
where the matrices W (a) and R(a) are defined by
W (a) =
(∫ 1
0
fi(a(u))fj(a(u))du
)p
i,j=1
,
R(a) =
(∫ 1
0
fi(a(u))fj(a(u))Q(a
′(u))du
)p
i,j=1
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and the function Q(·) is given by Q(t) =
∑∞
j=1 ρ(jt).
Note that only the first term in (2.4) [and (3.4)] depends on a (asymptotic)
design, and we propose to use this term for the construction of optimal
designs. If the function a(·) is the inverse of a continuous distribution with
density, say, ϕ, then a′(t) = 1/ϕ(t) and, for large n, the first term of the
covariance matrix can be approximated by the matrix V (ϕ)/n, where the
p× p matrix V is given by
V (ϕ) := σ2(W−1(ϕ) + 2γW−1(ϕ)R(ϕ)W−1(ϕ)).(3.5)
In (3.5) the matrices W (ϕ) and R(ϕ) have the form
W (ϕ) =
(∫
T
fi(t)fj(t)ϕ(t)dt
)p
i,j=1
,
R(ϕ) =
(∫
T
fi(t)fj(t)Q(1/ϕ(t))ϕ(t)dt
)p
i,j=1
.
A density will be called an asymptotic optimal density ϕ∗, if it minimizes an
appropriate functional of the matrix V (ϕ). Numerous criteria have been pro-
posed in [Silvey (1980), Atkinson and Donev (1992), Pukelsheim (1993)] and,
exemplarily, we consider the D- and c-optimality criteria which minimize
−detV (ϕ) and cTV (ϕ)c for a given vector c ∈Rp, respectively. The applica-
tion of the proposed methodology to other optimality criteria is straightfor-
ward. The general procedure for constructing an efficient design minimizing
a given functional of the covariance matrix of the least squares estimate is
as follows:
(1) Specify the correlation function ρ(·) in (3.2) and compute Q(·).
(2) Compute the asymptotic optimal design density ϕ∗ that minimizes an
appropriate functional of the matrix V (ϕ) in (3.5).
(3) Derive the exact design for a fixed sample size n by calculation of the
quantiles of the distribution function Φ∗ that corresponds to ϕ∗, namely,
ti,n = (Φ
∗)−1
(
i− 1
n− 1
)
; i= 1, . . . , n.(3.6)
The optimal density ϕ∗ in step (2) can be determined as follows. We consider
the parametric representation of a density by a polynomial in the form
ϕ(t) =
(p0 + p1t+ · · ·+ prt
r)+∫
T (p0 + p1t+ · · ·+ prt
r)+ dt
and apply the Nelder–Mead algorithm to find the optimal density that min-
imizes the specified functional of the matrix V (ϕ) with respect to p0, . . . , pr.
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One can run the algorithm for different degrees of the polynomial and differ-
ent initial values and choose the density corresponding to the minimal value
of the optimality criterion. All integrals can be calculated by the Simpson
quadrature formula. We found that the minimal value of the criterion is
negligibly decreasing for polynomials of degree larger than r = 6. We also
investigated the case where a density is represented in terms of rational, ex-
ponential or spline functions. The results were very similar and, on the basis
of our numerical experiments, we can conclude that the optimal density ϕ∗
can be very well approximated by 6-degree polynomials.
The derived designs from the asymptotic theory can be used to construct
efficient designs for a given sample size as specified in step (3) of the algo-
rithm. Alternatively, exact optimal designs can be determined by employing
the derived designs as initial values in a (discrete) optimization procedure.
More precisely, for the determination of an exact optimal design, the above
procedure can be extended by the fourth step:
(4) Determine an exact optimal design, that minimizes a functional of the
covariance matrix in (2.4), by using the Nelder–Mead algorithm with an
initial n-point design, which has been found in step (3).
We illustrate this methodology for a quadratic regression model by the fol-
lowing example. Also, in Section 4 we extend the approach for designing
for nonlinear models and investigate its performance for the compartmen-
tal model. In particular, we demonstrate that the designs derived from the
asymptotic consideration are very efficient compared to exact optimal de-
signs.
Example 1 (Quadratic regression). We illustrate the proposed approach
for constructing optimal designs for the classical quadratic regression model
with homoscedastic errors. For this model, we have p= 3, f1(t) = 1, f2(t) = t,
f2(t) = t
2 and T = [−1,1]. Let the correlation function in (3.2) be given by
ρ(t) = e−λt and
rn(t) = e
−λnt, λ > 0.(3.7)
The asymptotic D-optimal densities for different choices of the parameters
λ and γ are shown in Figure 1. Note that the numerically calculated optimal
design densities are symmetrical, but we were not able to prove the symmetry
of the asymptotic optimal density. We observe that the D-optimal density
converges to the density of the uniform design, if γ→ 1 or λ→ 0. On the
other hand, if γ→ 0 or λ→∞, it can be seen that the asymptotic D-optimal
design density is more concentrated at the points −1, 0 and 1, which are
the points of the exact D-optimal design for the quadratic fixed effect model
with uncorrelated observations [see Gaffke and Krafft (1982)]. Such behavior
is natural because the errors are less correlated as γ→ 0 or λ→∞.
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Fig. 1. Asymptotic D-optimal design densities for least squares estimation in a random
effect quadratic model for different choices of parameters in the covariance function (2.2)
with r(t) defined by (3.7). Right panel γ = 0.6; left panel λ= 0.2.
Further, we investigate the efficiency of an exact design derived from the
asymptotic theory for least squares estimation, where the parameters in the
correlation function (2.2) are given by
γ = 0.6, σ2 = 0.5, Vp = diag(σ
2
β1 , σ
2
β2) = diag(0.3
2,0.32).(3.8)
Let ξun be an n-point equidistant design and ξ
a
n be an n-point design obtained
by the transformation (3.6) from the asymptotic optimal density. The points
of the design ξan and the exact optimal designs for least squares estimation
for λ = 1.2 are displayed in the left part of Figure 2. In the right part of
Figure 2, we present the efficiencies for ordinary least squares estimation,
effOLS(ξ) =
(
det[(XTX)−1XTVεX(X
TX)−1 + Vp]
det[(XTOLSXOLS)
−1XTOLSVεXOLS(X
T
OLSXOLS)
−1 + Vp]
)1/p
,
and for weighted least squares estimation,
effWLS(ξ) =
(
det[XT (Vε +XVpX
T )−1X]
det[XTWLS(Vε +XWLSVpX
T
WLS)
−1XWLS]
)1/p
for two designs: the design ξan, derived from asymptotic theory, and the
uniform design ξun. Here X denotes the design matrix obtained for the design
ξ under investigation, while XOLS and XWLS correspond to the optimal
exact design for ordinary and weighted least squares estimation respectively.
We observe that the design points concentrate in three regions containing
the points of the exact D-optimal design for a quadratic regression with
uncorrelated errors. It is also noteworthy that the designs derived from the
asymptotic theory are very efficient, in particular, for weighted least squares
estimation.
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Fig. 2. Left part: Various designs for ordinary and weighted least squares estimation
in the random effect quadratic regression model. Exact D-optimal designs derived from
asymptotic theory: ball; exact D-optimal for ordinary least squares estimation: diamond;
exact D-optimal designs for weighted least squares estimation: triangle. Right part: Effi-
ciency of the designs ξan and equidistant design ξ
u
n for ordinary and weighted least squares
estimation. The parameters are given by (3.8), where λ= 1.2.
4. Nonlinear random effect models. In this section we extend the method-
ology to the case of nonlinear random effect models, which have found con-
siderable interest in the literature on pharmacokinetics. In this case, the
results of experiments are modeled by
Yij = η(tj , bi) + εij , i= 1, . . . ,K; j = 1, . . . , n.(4.1)
Since the model (4.1) is nonlinear with respect to the variables bi, there is
no analytical expression for the likelihood function and various approxima-
tions have been considered in the literature [see Mentre´, Mallet and Baccar
(1997), Retout, Mentre´ and Bruno (2002), Retout and Mentre´ (2003), among
others]. These approximations are used for the calculation of the maximum
likelihood estimate and the corresponding Fisher information matrix. Al-
ternatively, an estimate of the population mean β can be obtained as an
average of the nonlinear least squares estimates bˆi for the different individ-
uals, but due to the nonlinearity of the model, an explicit representation of
the corresponding covariance matrix cannot be derived. Following Retout
and Mentre´ (2003), we employ a first-order Taylor expansion to derive an
approximation of this covariance matrix. To be precise, we obtain (under
suitable assumptions of differentiability of the regression function) the ap-
proximation
η(t, b)≈ η(t, β) + g(t, β)(b− β)T ,(4.2)
where
g(t, b) =
∂η(t, b)
∂b
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denotes the gradient of the regression function with respect to b. This means
that the nonlinear model (4.1) is approximated by the linear model (4.2).
For the construction of the optimal design, we assume that knowledge about
the parameter β is available from previous or similar experiments. This cor-
responds to the concept of locally optimal designs, introduced by Chernoff
(1953) in the context of fixed effect nonlinear regression models. Usually,
locally optimal designs serve as benchmarks for commonly used designs and
are the basis for the construction of optimal designs with respect to more
sophisticated optimality criteria including the Bayesian and minimax ap-
proach [see Chaloner and Verdinelli (1995) or Dette (1995)].
Following the discussion in Section 3, we define the function f(t, b) =
g(t, b)/h(t) to account for heteroscedasticity. Note that the covariance matrix
of the nonlinear least squares estimate in the model (4.1) is approximated
by replacing the matrix X in model (2.1) with f(t) = f(t, b)|b=β , and the
methodology described in Sections 2 and 3 can be applied to determine
efficient designs. In the context of dose finding studies, it has been shown
by means of a simulation study that the approximation (4.2) has sufficient
accuracy for the construction of optimal designs [see Section 5 in Dette et al.
(2008) for more details].
We further illustrate this concept by giving several examples for the case of
homoscedastic errors. First, we investigate D- and c-optimal designs for the
random effect model, which has recently been studied by Atkinson (2008).
Next, we re-analyze the UzaraR© and Lanicor R© trials introduced in Section 1.
4.1. D-optimal design for a random effect compartmental model. We
consider the random effect compartmental model with first-order absorp-
tion,
η(t, b) =
b1
b1 − b2
(e−b2t − e−b1t).(4.3)
The model (4.3) is a special case of the Bateman function, defined in the
introduction [see Garrett (1994)], and has found considerable attention in
chemical sciences, toxicology and pharmacokinetics [see, e.g., Gibaldi and
Perrier (1982)]. The optimal design problem in the compartmental fixed ef-
fect model has been studied by numerous authors [see, e.g., Box and Lucas
(1959), Atkinson et al. (1993), Dette and O’Brien (1999), Biedermann, Dette
and Pepelyshev (2004), among others], but much fewer results are available
under the assumption of random effects. Recently optimal approximate de-
signs for a random-effect compartmental model (4.3) have been determined
by Atkinson (2008), but we did not find results about exact designs for these
models in the presence of correlated errors. In the present paper we derive
such designs from the asymptotic optimal design density and compare these
designs with the exact optimal designs.
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Fig. 3. Asymptotic D-optimal design densities for nonlinear least squares estimation in
the compartmental model (4.3) for different choices of the parameters in the covariance
function (2.2) with r(t) defined by (3.7). Left part: λ= 0.2; right part: γ = 0.6.
Note that the gradient of the function η(t, b) with respect to b is given by
g(t, b) =
(
b2(e
−b1x − e−b2x) + (b1
2x− b1b2x)e
−b1x
(b1 − b2)2
,
(4.4)
b1(e
−b1x − e−b2x) + (b1
2x− b1b2x)e
−b2x
(b1 − b2)2
)T
.
In order to illustrate the methodology, we consider the same scenario as in
Atkinson (2008) and assume that the parameters of the population and error
distributions are the following: β(0) = (1,0.5)T ,
γ = 0.6, σ2 = 0.01, Vp = diag(σ
2
β1 , σ
2
β2) = diag(0.1
2,0.052),(4.5)
and the design space is given by the interval T = [0,10]. We assume that the
function r(t) in (2.2) is given by (3.7). The asymptotic D-optimal design
densities for different values of the parameters are shown in Figure 3. We
observe that, for γ→ 1 or λ→ 0, theD-optimal design densities approximate
the uniform design, while, for larger values of λ or small values of γ, the
asymptotic D-optimal designs put more weight at two specific regions of the
design space. This fact corresponds to intuition, because the (approximate)
D-optimal design for the model (4.3) with uncorrelated observations is a
two-point design [see, e.g., Box and Lucas (1959)].
Further, we investigate the performance of the uniform and an exact de-
sign derived from asymptotic theory. For this purpose we define ξun as an
n-point equidistant design {10/n,20/n, . . . ,10} and ξan as the n-point design
obtained by the transformation
tj = (Φ
∗)−1(j/(n+ 1)), j = 1, . . . , n,
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where Φ∗ denotes the distribution function corresponding to the asymptotic
D-optimal design density. Note this transformation is slightly different from
the transformation (3.1) in order to exclude the point 0 from the design
points. Obviously, it is not reasonable to take observations t= 0 in model
(4.3), because it is assumed that the drug is administered at time t = 0.
The corresponding points of the exact designs are depicted in the left part
of Figure 4, while the right part of the figure shows the D-efficiencies of the
different designs. We observe that the designs derived from the asymptotic
theory have a substantially larger D-efficiency compared to the uniform
design. For example, for n = 6, the D-efficiency of the uniform design is
approximately 50% for ordinary and weighted nonlinear least squares esti-
mation, while the D-efficiency of the design ξan is close to 90%.
It is worthwhile to mention that, in nonlinear random effect models, the
optimal designs depend additionally on the mean β of the distribution of the
population parameters bi. Therefore, it is of interest to investigate the sensi-
tivity of the designs with respect to a misspecification of this parameter. For
a study of the impact of such a misspecification on the efficiency of the result-
ing designs, we consider the case n= 4 and n= 6 and the corresponding de-
signs ξa4 = {1.04,2.01,3.16,4.33} and ξ
a
6 = {0.83,1.47,2.32,3.30,4.20,5.20},
respectively. In Figure 5 we display the efficiencies(
det[(XTX)−1XTVεX(X
TX)−1 + Vp]
det[(XTOLS,βXOLS,β)
−1XTOLS,βVεXOLS,β(X
T
OLS,βXOLS,β)
−1 + Vp]
)−1/p
(4.6)
for different values of β. Here X denotes the design matrix obtained from
the design ξan under the assumption that β
(0) = (1,0,5)T , while the matrix
Fig. 4. Left part: Various designs for ordinary and weighted nonlinear least squares es-
timation in the compartmental model (4.3). Exact D-optimal designs derived from asymp-
totic theory: ball; exact D-optimal for ordinary least squares estimation: diamond; exact
D-optimal designs for weighted least squares estimation: triangle. Right part: Efficiency of
the designs ξan and ξ
u
n for ordinary and weighted least squares estimation. The parameters
are given by (4.5), where λ= 0.2.
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Fig. 5. D-efficiencies of the designs ξa4 = {1.04,2.01,3.16,4.33} (left part) and the design
ξa6 = {0.83,1.47,2.32,3.30, 4.20,5.20} (right part) (these designs are obtained from asymp-
totic density) for nonlinear least squares estimation in the random effect compartmental
model (4.3), if the mean of the population distribution has been misspecified. The param-
eters of the population distribution are given by (4.5) with λ= 0.2.
XOLS,β corresponds to the exact D-optimal design for nonlinear least squares
estimation for a specific β. The efficiencies are plotted in Figure 5 for the
rectangle [β
(0)
i − 3σβ(0)
i
, β
(0)
i +3σβ(0)
i
] = [0.7,1.3]× [0.35,0.65]. It can be seen
that the exact optimal design, derived from the asymptotic theory, has a
high D-efficiency with respect to misspecification of the population mean β
over a broad range.
4.2. Optimal designs for estimating the AUC. In some bioavailability
studies, the aim of experiments is the estimation of the area under curve
AUC=
∫ ∞
0
η(t, β)dt.
For the compartmental model (4.3), we obtain AUC = 1/b2. It can be shown
that the locally AUC-optimal design for model (4.3) minimizes the variance
of the nonlinear least squares estimate for the parameter β2. This variance
is approximately proportional to
(0,1)((XTX)−1XTVεX(X
TX)−1 + Vp)(0,1)
T .
This expression corresponds to the c-optimality criterion, which has been
discussed extensively in the literature for fixed effect models with uncorre-
lated observations [see, e.g., Ford, Torsney and Wu (1992), Fan and Chaloner
(2003) and Dette et al. (2008), among others]. The asymptotic optimal de-
sign densities for estimating the area under the curve are shown in Figure
6. We observe again that the optimal density is close to the uniform design
density if λ→ 0 or γ → 1. On the other hand, if λ is large or γ → 0, the
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Fig. 6. Asymptotic optimal densities for estimating the area under the curve in the com-
partmental model (4.3) for different choices of the parameters in the covariance function
(2.2) with r(t) defined by (3.7). Left part: λ= 0.2, right part: γ = 0.6.
AUC-optimal design density has a narrow support. This fact reflects that
the optimal design for estimating the area under the curve in the fixed effect
compartmental model with uncorrelated observations is a one-point design.
In Figure 7 we show the designs derived from the asymptotic optimal design
densities, and the exact optimal designs for estimating the area under the
curve in the compartmental model. We observe that the designs ξan, derived
from the asymptotic optimal design density, are very close to the exact
optimal designs for least squares estimation of the area under the curve.
Moreover, the design ξan yields a substantial improvement in efficiency com-
pared to the uniform design. Again we observe that the designs derived for
ordinary least squares estimation also have excellent efficiencies for weighted
least squares estimation of the AUC (see the right part of Figure 7).
4.3. Optimal designs for estimating the AUC in the UzaraR© and LanicorR©
trials. In this section we consider the optimal design problem for estimat-
ing the AUC in the two examples presented in the introduction. The med-
ical background of these examples was a small pilot trial of 4 patients
[Thu¨rmann, Neff and Fleisch (2004)], where it was observed that patients
taking the over-the-counter herbal diarrhea medication UzaraR© (in the form
of drops, i.e., oral application) showed high values in medical assays designed
to measure the blood serum concentration of digitoxin, a potent treatment
against heart insufficiency. This is caused by the chemical similarity of these
two substances and can result in major complications in establishing treat-
ment programs for heart insufficiency. It was thus decided to compare the
pharmacokinetic properties of an oral application of UzaraR© to the proper-
ties of the usual intravenous application of a regular digitoxin medication
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Fig. 7. Left part: Various designs for estimating the area under the curve in the compart-
mental model (4.3). Designs derived from asymptotic theory: ball; exact optimal designs
for least squares estimation of the area under the curve: diamond; exact optimal designs
for weighted least squares estimation: triangle. Right part: Efficiency of the designs ξan and
ξun for ordinary and weighted least squares estimation of the AUC. The parameters are
given by (4.5), where λ= 1.2.
(Lanicor R©) on a larger sample size of 18 patients, with 15 measurements
each. The main focus of the comparison was the area under the concentra-
tion curve as a measure of the total effect of an application. A preliminary
design was proposed by experts in order to allow precise estimation of this
property, and the study was carried out according to this design. We will
now investigate the efficiency of this and a naively chosen equally spaced
design compared to a design generated using the methods presented in this
paper.
In order to compute the design densities, it is necessary to estimate the
parameters for both of the models. To do so, we used the full 18 patient data
set, however, this could have been done as well using only the 4 patients of
the pilot study. We estimated parameters using a combination of maximum
likelihood and least squares techniques [see Pinheiro and Bates (1995)]. For
the intravenous part corresponding to model (1.1), we have received the
estimates βˆ = (30,0.75)T ,
Vˆp =
(
9 0.189
0.189 0.0049
)
for the population parameters, while the estimates of the parameters in the
covariance matrix (1.3) are given by γˆ = 0.8, λˆ= 0.05, σˆ2 = 0.6.
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For the oral application corresponding to model (1.2), the estimates of
the parameters are given by βˆ = (0.2,0.135,28)T ,
Vˆp =

0.0025 0.0019 00.0019 0.0016 0
0 0 144


and γˆ = 0.8, λˆ= 0.01, σˆ2 = 0.2. Note that the entries in the positions (1,3),
(2,3), (3,1) and (3,2) are not identical 0, but smaller than 10−5. Based
on a preliminary discussion with experts, the physicians decided to take
measurements for both experiments at nearly identical (nonoptimized) time
points
0,0.5,1,1.5,2,3,4,5,6,8,10,12,15,24, 36
and
0.25,0.75,1.25,2,3,4,5,6,8, 10,12,15,24,36,
respectively. Note that in the second design an additional measurement was
taken at t=−0.25, that is, before the intravenous injection. Since this point
is out of the scope of the exponential evasion model, the observation at this
time has been excluded from further considerations. Thus, the Lanicor R©
trial has n= 14 observations.
For the estimated parameters, we have derived the asymptotic optimal
design densities, which are depicted in the left and right part of Figure 8 for
the UzaraR© and Lanicor R© trials, respectively, where the design interval is
given by T = [0,36]. The resulting designs from these densities are given by
2.09,4.55,7.49,10.8,13.9, 16.8,19.2, 21.5,23.6, 25.7,27.7, 29.8,31.9, 34.0,36
Fig. 8. Asymptotic optimal density for estimating the area under the curve in the
3-parameter Bateman (left part) and exponential evasion model (right part).
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for the UzaraR© trial and
0.432,0.85,1.25,1.66,2.06,2.46,2.87,3.28,3.7,4.12,4.55,5.01,5.54,36
for the Lanicor R© trial. This means that the asymptotic optimal design for
the oral application is close to an equally spaced design, while the optimal de-
sign for the intravenous application is much more focused on measurements
at early time points. This result is plausible in an exponential elimination
model. Calculating the efficiencies for ordinary least squares estimation of
these asymptotic optimal designs compared to the exact optimal design, we
obtain efficiencies 0.99 and 0.95, respectively, indicating that these designs
are quite good.
Upon numerical studies, we can further conclude that the constructed
designs are robust to misspecification of the initial guess of parameters. For
example, variations of λ (or any of the other parameters) by up to 50% yield
a drop of efficiency by less than 0.02.
Note that in the examples presented in Sections 3, 4.1 and 4.2, the ef-
ficiencies of the derived designs for weighted least squares estimation are
very similar to the efficiencies for ordinary least squares estimation, and
a similar observation has been made for the two trials under investigation.
The efficiencies for weighted least squares estimation of the designs based on
the asymptotic density are 99% (UzaraR©) and 97% (Lanicor R©), even better
than the efficiencies for ordinary least squares estimation.
We now investigate the performance of the designs which were actually
used in the clinical trial. We found that these designs have efficiency 0.96
and 0.92 for estimating the AUC through OLS estimation in the UzaraR© and
Lanicor R© trials, respectively. Thus, the preliminary designs, recommended
by experts, are rather efficient in both trials.
Let us now investigate the performance of naively chosen equidistant de-
signs: the design
0,2.6,5.1,7.7,10.3,12.8,15.4,18.0,20.6,23.1,25.7,28.3,30.8,33.4,36
for the UzaraR© trial, and the design
0,2.8,5.5,8.3,11.1,13.9, 16.6,19.4, 22.2,24.9, 27.7,30.5, 33.2,36
for the Lanicor R© trial. Comparing these designs to the optimal designs, we
obtain efficiencies of 0.97 and 0.41 for ordinary least squares estimation of
the AUC in the UzaraR© and Lanicor R© trials, respectively.
It was pointed out by a referee that it is of some interest to investigate the
performance of the optimal designs proposed in this paper for the estimation
of the variance of the random effects (i.e., the parameters of the matrix Vp).
These parameters are usually estimated by maximum likelihood techniques
[see Retout and Mentre´ (2003), among others] and the corresponding infor-
mation matrix of these estimates is of a fundamentally different structure
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compared to the variance matrix of the least squares estimate. For the two
optimal designs we have calculated the D-efficiencies for estimating the di-
agonal elements of the matrix Vp, which are 96% and 79% in the Uzara
R©
and Lanicor R© trial, respectively. The designs actually used in the trial have
efficiency 98% and 85%, while the corresponding efficiencies of the uniform
designs are 98% and 63%, respectively. Thus, the proposed optimal designs
for AUC-estimation also have reasonable efficiency for estimation of the co-
variance matrix of the population distribution.
Summarizing the discussion in this example, we conclude that the equally
spaced design in the UzaraR© trial is very close to the optimal design deter-
mined by the proposed methodology, and it is for this reason very efficient.
However, the equally-spaced designs do not always have high efficiency. In
the Lanicor R© trial, the use of naively chosen designs yields considerably less
accurate estimates. For this reason, the application of experimental design
techniques in the context of pharmacokinetics trials is strictly recommended.
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